IL-17 ANTIBODY FORMULATION
The present invention provides pharmaceutical formulations for anti-IL-17 antibodies. These anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Polish |
Published |
30.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!